Pembrolizumab Plus Lenvatinib Approved for Endometrial Cancer

Cancer News

Article from Cancer Network curated by Editor in Chief George Lundberg, MD, who notes: 

The U.S. Food and Drug Administration (FDA) has approved a new combination therapy for certain advanced endometrial cancers.

Go to full article published by Cancer Network.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Back to Cancer Insights